dronabinol has been researched along with Allodynia in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.44) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (33.33) | 29.6817 |
2010's | 17 (37.78) | 24.3611 |
2020's | 11 (24.44) | 2.80 |
Authors | Studies |
---|---|
Britch, SC; Craft, RM | 2 |
Casey, SL; Mitchell, VA; Sokolaj, EE; Vaughan, CW; Winters, BL | 1 |
Baldasso, GM; Capasso, R; Cicco, P; de Assis, PM; Dutra, RC; Ferrarini, EG; Gouvêa, MC; Moreira, ELG; Paes, RS; Raposo, NRB | 1 |
Craft, RM; Freels, TG; Glodosky, NC; Gogulski, HY; McLaughlin, RJ | 1 |
Antunes, FTT; Gadotti, VM; Zamponi, GW | 1 |
Gobbi, G; Lopez-Canul, M; Pearl-Dowler, L; Posa, L; Teggin, A | 1 |
Campbell, CM; Caufield-Noll, C; DiRenzo, D; Finan, PH; Gajewski-Nemes, J; Letzen, JE; Mun, CJ; Peters, EN; Vandrey, R | 1 |
Abraham, AD; Clark, JJ; Kruse, LC; Land, BB; Leung, EJY; Rivera, ZMG; Wong, BA | 1 |
Cairns, EA; Kelly, MEM; Kulkarni, PM; Straiker, AJ; Szczesniak, AM; Thakur, GA; Thapa, D | 1 |
Bryk, M; Mlost, J; Starowicz, K | 1 |
King, KM; Myers, AM; Soroka-Monzo, AJ; Tallarida, RJ; Tuma, RF; Walker, EA; Ward, SJ | 1 |
Atwal, N; Casey, SL; Vaughan, CW | 1 |
Limebeer, CL; Parker, LA; Rock, EM | 1 |
Atwal, N; Casey, SL; Mitchell, VA; Vaughan, CW | 1 |
Carey, LM; Dhopeshwarkar, AS; Hohmann, AG; Li, AL; Lin, X; Liu, Y; Mackie, K; Makriyannis, A; Nikas, SP; Thomaz, AC | 1 |
Jungck, D | 1 |
Craft, RM; Davis, SM; Kandasamy, R | 1 |
Cornett, BL; Deng, L; Guindon, J; Hohmann, AG; Mackie, K; Makriyannis, A | 1 |
Lötsch, J; Oertel, BG; Walter, C | 1 |
Ehler, E; Hoggart, B; Hovorka, J; Lauder, H; Lejčko, J; Ratcliffe, S; Serpell, M; Simpson, KH; Taylor, L | 1 |
Leitl, MD; Negus, SS | 1 |
Hu, X; Jiang, L; Xiao, D; Xie, J; Xu, Y; Yu, L; Zhang, Y; Zhao, J | 1 |
Bao, Q; Hu, N; Jiang, L; Xiao, D; Xie, J; Yu, L; Zhao, J | 1 |
ElSohly, MA; Gul, W; Harris, HM; Sufka, KJ | 1 |
Gogos, JA; Harvey, R; Karayiorgou, M; Lai, D; O'Tuathaigh, CM; Tighe, O; Waddington, JL; Walsh, J | 1 |
Boeckxstaens, GE; Klooker, TK; Leliefeld, KE; Van Den Wijngaard, RM | 1 |
Deutsch, R; Donaghe, H; Gouaux, B; Marcotte, T; Sakai, S; Wilsey, B | 1 |
Bingel, U; Brooks, J; Lee, MC; Menon, DK; Ploner, M; Tracey, I; Wanigasekera, V; Wiech, K | 1 |
Dvorak, M; McGlone, F; Rukwied, R; Watkinson, A | 1 |
Burstein, S; Conrad, I; Hoy, L; Karst, M; Salim, K; Schneider, U | 1 |
Smith, PF | 1 |
Burstein, S; Hoy, L; Karst, M; Salim, K; Schneider, U | 1 |
Chapman, V; Clayton, NM; Elmes, SJR; Kendall, DA; Medhurst, SJ; Wilson, AW; Winyard, LA | 1 |
Cichewicz, DL; Haller, VL; Welch, SP | 1 |
Mitchell, VA; Vaughan, CW; Vuong, LA | 1 |
Abramson, I; Atkinson, JH; Bentley, H; Gouaux, B; Lazzaretto, D; Schulteis, G; Wallace, M; Wolfson, T | 1 |
Goffaux, P; Marchand, S; Potvin, S; Redmond, WJ | 1 |
Keniston, L; Lu, J; Mao, J; Mayer, DJ; Price, DD | 1 |
Maldonado, R; Valjent, E; Valverde, O; Zimmer, A; Zimmer, AM | 1 |
Fox, A; Gentry, C; James, I; Kesingland, A; McNair, K; Patel, S; Urban, L | 1 |
Chapman, V | 1 |
Colleoni, M; Conti, S; Costa, B; Giagnoni, G; Parolaro, D | 1 |
Burstein, SH; Hull, K; Hunter, SA; Latham, V | 1 |
2 review(s) available for dronabinol and Allodynia
Article | Year |
---|---|
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Chronic Pain; Dronabinol; Humans; Hyperalgesia; Medical Marijuana; Pain Measurement; Pain Threshold | 2020 |
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
Topics: Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Humans; Hyperalgesia; Neuralgia; Pain Management | 2020 |
8 trial(s) available for dronabinol and Allodynia
Article | Year |
---|---|
A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.
Topics: Adult; Aged; Analgesics; Cannabidiol; Diabetic Neuropathies; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Oral Sprays; Pain Management; Treatment Outcome | 2015 |
The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
Topics: Adult; Analgesics, Non-Narcotic; Cannabinoid Receptor Agonists; Cross-Over Studies; Dilatation, Pathologic; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Irritable Bowel Syndrome; Middle Aged; Pain Threshold; Placebos; Pressure; Rectum; Viscera; Young Adult | 2011 |
Low-dose vaporized cannabis significantly improves neuropathic pain.
Topics: Administration, Inhalation; Adult; Affect; Cannabis; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Linear Models; Male; Middle Aged; Neuralgia; Neuropsychological Tests; Pain Measurement; Pain Threshold; Patient Selection; Phytotherapy; Socioeconomic Factors; Treatment Outcome; Volatilization | 2013 |
Amygdala activity contributes to the dissociative effect of cannabis on pain perception.
Topics: Adult; Amygdala; Analgesics, Non-Narcotic; Antigens, Viral; Capsaicin; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Dronabinol; Heart Rate; Humans; Hyperalgesia; Male; Pain Perception; Placebos; Psychomotor Performance; Sensory System Agents; Young Adult | 2013 |
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Topics: Adult; Analgesics, Non-Narcotic; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Male; Middle Aged; Pain; Pain Measurement | 2003 |
Pain measurements and side effect profile of the novel cannabinoid ajulemic acid.
Topics: Adult; Aged; Cross-Over Studies; Dronabinol; Female; Humans; Hyperalgesia; Male; Middle Aged; Pain Measurement; Touch | 2005 |
Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Topics: Adult; Analgesics, Non-Narcotic; Cannabinoids; Cannabis; Capsaicin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Male; Marijuana Smoking; Neuropsychological Tests; Pain; Pain Measurement; Reference Values; Sensory System Agents; Sensory Thresholds; Time Factors | 2007 |
Analgesic and antihyperalgesic effects of nabilone on experimental heat pain.
Topics: Adolescent; Adult; Analgesics; Anti-Anxiety Agents; Cannabinoids; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hot Temperature; Humans; Hyperalgesia; Male; Pain | 2008 |
35 other study(ies) available for dronabinol and Allodynia
Article | Year |
---|---|
No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Freund's Adjuvant; Hyperalgesia; Inflammation; Locomotion; Male; Morphine; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sex Factors | 2021 |
Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Disease Models, Animal; Dronabinol; Hallucinogens; Hyperalgesia; Mice; Neuralgia | 2022 |
Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in mice.
Topics: Analgesics; Animals; Cannabis; Disease Models, Animal; Dronabinol; Fibromyalgia; Hyperalgesia; Mice; Reserpine | 2022 |
Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Dronabinol; Female; Hyperalgesia; Male; Rats | 2023 |
Vaporized cannabis extract-induced antinociception in male vs female rats with persistent inflammatory pain.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Chronic Pain; Dronabinol; Edema; Female; Humans; Hyperalgesia; Male; Rats | 2023 |
Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels.
Topics: Analgesia; Analgesics; Animals; Calcium Channels, T-Type; Dronabinol; Female; Hyperalgesia; Male; Mice; Pain; Receptors, Cannabinoid; Spinal Cord Dorsal Horn | 2023 |
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Dronabinol; Hyperalgesia; Male; Morphine; Neuralgia; Rats; Rats, Wistar | 2023 |
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain.
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Female; Hyperalgesia; Male; Mice; Morphine; Neuralgia; Sciatic Nerve; Self Administration; Vocalization, Animal | 2020 |
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
Topics: Allosteric Regulation; Animals; Cautery; Corneal Injuries; Disease Models, Animal; Dronabinol; Drug Synergism; Gene Knockout Techniques; Hyperalgesia; Indoles; Inflammation; Ligands; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2020 |
Single and combined effects of Δ
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Cannabidiol; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Vincristine | 2017 |
Cannabis constituent synergy in a mouse neuropathic pain model.
Topics: Analgesics; Animals; Cannabidiol; Cannabis; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia | 2017 |
Effect of cannabidiolic acid and ∆
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Cannabinoids; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Edema; Hyperalgesia; Inflammation; Male; Pain; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2018 |
THC and gabapentin interactions in a mouse neuropathic pain model.
Topics: Analgesics; Animals; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Gabapentin; Hyperalgesia; Male; Mice, Inbred C57BL; Motor Activity; Neuralgia; Sciatic Nerve; Time Factors; Touch | 2019 |
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
Topics: Analgesics, Opioid; Animals; Cannabinoids; Cell Line; Chromones; Dronabinol; Drug Tolerance; HEK293 Cells; Humans; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Neuralgia; Paclitaxel; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2019 |
[Patient with pain after quadriplegia. From black sheep of the home to favorite of all].
Topics: Affect; Analgesics, Non-Narcotic; Cervical Vertebrae; Chronic Pain; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyperalgesia; Male; Middle Aged; Muscle Spasticity; Narcotics; Pain Measurement; Phytotherapy; Quadriplegia; Spinal Fractures; Suicide, Attempted | 2004 |
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
Topics: Animals; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Edema; Estrous Cycle; Female; Hyperalgesia; Male; Motor Activity; Pain Measurement; Pain Threshold; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Sex Characteristics; Time Factors | 2013 |
Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Chemokine CCL2; Chromones; Disease Models, Animal; Dronabinol; Female; Hyperalgesia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Spinal Cord; Tumor Necrosis Factor-alpha | 2015 |
THC may reproducibly induce electrical hyperalgesia in healthy volunteers.
Topics: Adult; Dronabinol; Female; Healthy Volunteers; Humans; Hyperalgesia; Pain; Pain Threshold; Young Adult | 2015 |
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Bupropion; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Formaldehyde; Hyperalgesia; Ketoprofen; Male; Medial Forebrain Bundle; Morphine; Neuralgia; Rats; Rats, Sprague-Dawley; Self Stimulation | 2016 |
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
Topics: Animals; Apoptosis; Blotting, Western; Bone Marrow; Cannabinoid Receptor Agonists; Cell Proliferation; Cells, Cultured; Cytokines; Dronabinol; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Hyperalgesia; Immunomodulation; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sciatic Nerve; Signal Transduction; Transcriptional Activation; Up-Regulation | 2016 |
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cell Line; Dronabinol; Drug Carriers; Drug Delivery Systems; Hyperalgesia; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Nanoparticles; Neuralgia; Oligopeptides; Oxidation-Reduction; Pain Management; Silicon Dioxide | 2016 |
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice.
Topics: Analgesics; Animals; Cannabidiol; Cisplatin; Dronabinol; Drug Combinations; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Plant Extracts | 2016 |
Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Behavior, Animal; Catechol O-Methyltransferase; Dronabinol; Female; Hyperalgesia; Male; Mice; Mice, Knockout; Mutagenesis; Nerve Tissue Proteins; Neuregulin-1; Pain Measurement; Pain Threshold; Reaction Time; Sex Factors | 2010 |
Cannabinoid agonists attenuate capsaicin-induced responses in human skin.
Topics: Adult; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Dronabinol; Female; Humans; Hyperalgesia; Male; Pain Measurement; Skin | 2003 |
GW-1000. GW Pharmaceuticals.
Topics: Administration, Oral; Analgesics; Animals; Biological Availability; Canada; Cannabidiol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dronabinol; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Humans; Hyperalgesia; Investigational New Drug Application; Mice; Molecular Structure; Multiple Sclerosis; Patents as Topic; Peripheral Nervous System Diseases; Phytotherapy; Plant Extracts; Plant Preparations; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Structure-Activity Relationship | 2004 |
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
Topics: Analgesics; Animals; Cannabinoids; Carrageenan; Dronabinol; Drug Combinations; Hyperalgesia; Inflammation; Male; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome; Weight-Bearing | 2005 |
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Topics: Acetaminophen; Amides; Analgesics; Animals; Arachidonic Acids; Benzamides; Benzoquinones; Camphanes; Capsaicin; Carbamates; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Ethanolamines; Hyperalgesia; Male; Mesencephalon; Mice; Mice, Inbred ICR; Narcotic Antagonists; Pain; Palmitic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid; Rimonabant; Spinal Cord; TRPV Cation Channels | 2006 |
Actions of N-arachidonyl-glycine in a rat neuropathic pain model.
Topics: Analgesics; Animals; Arachidonic Acids; Area Under Curve; Camphanes; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Glycine; Hyperalgesia; Male; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Sciatica | 2008 |
Two distinctive antinociceptive systems in rats with pathological pain.
Topics: Analgesics, Non-Narcotic; Animals; Cannabinoids; Dizocilpine Maleate; Dronabinol; Drug Tolerance; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Morphine; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sciatic Nerve | 2000 |
Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice.
Topics: Acute Disease; Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Body Temperature; Body Weight; Brain; Chronic Disease; Dronabinol; Drug Tolerance; Enkephalins; Hyperalgesia; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Protein Precursors; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Substance Withdrawal Syndrome | 2000 |
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dronabinol; Hyperalgesia; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sciatica | 2001 |
Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats.
Topics: Animals; Cannabinoids; Dronabinol; Evoked Potentials; Hyperalgesia; Ligation; Male; Neural Inhibition; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord; Spinal Nerves | 2001 |
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
Topics: Acute Disease; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Carrageenan; Disease Models, Animal; Dronabinol; Edema; Endocannabinoids; Ethanolamines; Hindlimb; Hyperalgesia; Indomethacin; Inflammation; Male; Motor Activity; Palmitic Acids; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2002 |
Letter: Tetrahydrocannabinol and chemotherapy.
Topics: Adult; Bone Neoplasms; Cannabis; Dronabinol; Female; Humans; Hyperalgesia; Hyperesthesia; Leukemia, Myeloid, Acute; Male; Pain; Phytotherapy; Vomiting | 1976 |
Cannabinoids and pain responses: a possible role for prostaglandins.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Dronabinol; Female; Hot Temperature; Hyperalgesia; Hyperesthesia; Indomethacin; Mice; Pain; Prostaglandins | 1988 |